KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 116 filers reported holding KURA ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,787,218 | +18.5% | 195,967 | +37.5% | 0.00% | +33.3% |
| Q2 2023 | $1,507,701 | +41.8% | 142,505 | +63.9% | 0.00% | +50.0% |
| Q1 2023 | $1,063,592 | -19.2% | 86,966 | -18.0% | 0.00% | -33.3% |
| Q4 2022 | $1,316,910 | -20.5% | 106,117 | -12.6% | 0.00% | -25.0% |
| Q3 2022 | $1,657,000 | -25.5% | 121,442 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $2,224,000 | +63.0% | 121,442 | +42.9% | 0.01% | +150.0% |
| Q1 2022 | $1,364,000 | +68.4% | 84,998 | +46.8% | 0.00% | +100.0% |
| Q4 2021 | $810,000 | -14.6% | 57,896 | +14.1% | 0.00% | -50.0% |
| Q3 2021 | $949,000 | +20.1% | 50,731 | +33.7% | 0.00% | +100.0% |
| Q2 2021 | $790,000 | -12.6% | 37,943 | +18.5% | 0.00% | -50.0% |
| Q1 2021 | $904,000 | -13.5% | 32,016 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,045,000 | +914.6% | 32,016 | +324.7% | 0.00% | – |
| Q4 2019 | $103,000 | -9.6% | 7,538 | 0.0% | 0.00% | – |
| Q3 2019 | $114,000 | – | 7,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |